| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 04/08/2004 | WO2004028451A2 β-HYDROXYPHENYLALKYLAMINES AND THEIR USE FOR TREATING GLAUCOMA |
| 04/08/2004 | WO2004028446A2 Formulation and method for treating skeletal muscle degeneration caused by malnutrition and disease |
| 04/08/2004 | WO2004011637A3 Modified adamts4 molecules and method of use thereof |
| 04/08/2004 | WO2004009072A3 Tetrapropylammonium tetrathiomolybdate and related compounds for anti-angiogenic therapies |
| 04/08/2004 | WO2004009061A3 Bioavailability/bioefficacy enhaning activity of cuminum cyminum and extracts and fractions thereof |
| 04/08/2004 | WO2004007764A3 Chromosome 3, 5 and 11 genes involved in premature canities |
| 04/08/2004 | WO2004007512A3 Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase |
| 04/08/2004 | WO2004006911A3 Compositions intended for the treatment of peripheral neuropathies, preparation thereof and uses of same |
| 04/08/2004 | WO2004006833A3 Bowel cleansing composition |
| 04/08/2004 | WO2004000224A3 Enhancing treatment of mdr cancer with adenosine a3 antagonists |
| 04/08/2004 | WO2004000223A3 Rapidly disintegrating formulations for treating or preventing mucositis |
| 04/08/2004 | WO2004000205A3 Novel tetracyclic arylcarbonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them |
| 04/08/2004 | WO2003105775A3 Dihydrate dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compostions thereof |
| 04/08/2004 | WO2003100087A3 Regulation of novel human asparagine-hydroxylases |
| 04/08/2004 | WO2003100023A3 Manipulation of the rate of gastrointestinal transit by modulating intestinal methane concentration |
| 04/08/2004 | WO2003089000A3 Anti-hiv composition, production method thereof and medicament |
| 04/08/2004 | WO2003087121A8 Branched polyamine steroid derivatives |
| 04/08/2004 | WO2003086314A3 Tyrosine kinase inhibitors |
| 04/08/2004 | WO2003084503A3 P38 kinase inhibitors for treating mucus hypersecretion_ |
| 04/08/2004 | WO2003083135A3 Diagnostics and therapeutics for diseases associated with neuropeptide ff receptor 2 (npff2) |
| 04/08/2004 | WO2003080024A3 Nanoparticulate compositions of map kinase inhibitors |
| 04/08/2004 | WO2003076602A3 Use of l-$g(a)-lysophosphatidycholine to obtain the differentiation of monocytes in mature dendritric cells in vivo |
| 04/08/2004 | WO2003066077A3 Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (nmu1) |
| 04/08/2004 | WO2003065006A3 Methods and compositions for treating cancer |
| 04/08/2004 | WO2003063893A3 Fgfr agonists |
| 04/08/2004 | WO2003057225A3 Phosphate transport inhibitors |
| 04/08/2004 | WO2003047519A3 'compressed annular tablet with molded triturate tablet for oral and intraoral' |
| 04/08/2004 | WO2003046581A3 Methods for diagnosis and treatment of epithelial-derived cancers,such as colorectal cancers and kidney cancers |
| 04/08/2004 | WO2003044037A3 Process for the manufacture of human mononuclear phagocytic leukocytes |
| 04/08/2004 | WO2003022123A9 Methods of kidney transplantation utilizing developing nephric tissue |
| 04/08/2004 | WO2003014300A3 TRPS AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE |
| 04/08/2004 | WO2003012030A3 Isoform-selective inhibitors and activators of pde3 cyclic |
| 04/08/2004 | WO2003003806A3 Dye-azide compounds for dual phototherapy |
| 04/08/2004 | WO2003001968A8 Compositions and methods for inhibiting platelet activation and thrombosis |
| 04/08/2004 | WO2002099074A8 Slc7s as modifiers of the p53 pathway and methods of use |
| 04/08/2004 | WO2002092008A3 Use of il-18 inhibitors for the treatement or prevention of sepsis |
| 04/08/2004 | WO2002076391B1 Microbial feeds for aquaculture and agriculture |
| 04/08/2004 | WO2002076173A3 Inhibitors of glycosaminoglycans |
| 04/08/2004 | WO2002058546A3 Methods for screening for substances which inhibit fp prostanoid receptor |
| 04/08/2004 | US20040068268 Devices and methods for the restoration of a spinal disc |
| 04/08/2004 | US20040068207 Active oxygen generator containing photosensitizer for ultrasonic therapy |
| 04/08/2004 | US20040068141 Process for the synthesis of trifluorophenylacetic acids |
| 04/08/2004 | US20040068120 Arylated furan- and thiophenecarboxamides, processes for their preparation, their use as medicaments, and pharmaceutical preparations comprising them |
| 04/08/2004 | US20040068108 Disaccharide sequences formed by uronic acid and hexose as to form polysaccharides of 8-24 monosaccharide units whose hydroxyl groups are substituted by alkyl or sulphate groups; possible to modulate activities of glycosaminoglycans type |
| 04/08/2004 | US20040068014 Medicinal compositions comprising diclofenac and ornoprostil |
| 04/08/2004 | US20040068007 Diclofenac salt of lidocaine |
| 04/08/2004 | US20040068005 Pharmaceutical combinations |
| 04/08/2004 | US20040067995 Synergistic mixture; anticoagulants, thrombosis therapy |
| 04/08/2004 | US20040067992 Compositions of a cyclooxygenase-2 selective inhibitor and a carbonic anhydrase inhibitor for the treatment of neoplasia |
| 04/08/2004 | US20040067990 Thiazolyl inhibitors of Tec family tyrosine kinases |
| 04/08/2004 | US20040067989 Anticancer agents; antiallergens; immunology diseases; antiinflamamtory agents |
| 04/08/2004 | US20040067967 Controlling adenosine triphosphatase gene expression |
| 04/08/2004 | US20040067962 1-(2-m-methanesulfonamidophenylethyl)-4-(m-trifluoromethylphenyl) piperazine and pharmaceutically acceptable salts and solvents thereof |
| 04/08/2004 | US20040067961 Organ grafting; antiarthritic agents; inflammatory bowel disease |
| 04/08/2004 | US20040067957 Methods of treating or preventing restless leg syndrome using sibutramine metabolites |
| 04/08/2004 | US20040067956 Treatment of motor fluctuations |
| 04/08/2004 | US20040067954 Benzoylpyridazines |
| 04/08/2004 | US20040067953 Combination therapy for treating, preventing or managing proliferative disorders and cancers |
| 04/08/2004 | US20040067950 High affinity ligands for nociceptin receptor ORL-1 |
| 04/08/2004 | US20040067942 Therapeutic combinations of erb B kinase inhibitors and antineoplastic therapies |
| 04/08/2004 | US20040067937 Guanylate cyclase stimulant; cardiovascular disorders; thrombosis; antiischemic agents; sexual disorders; antiinflammatory agents; central nervous system disorders |
| 04/08/2004 | US20040067933 Prevent bile acid transportation; antilipemic agents; anticholesterol agents |
| 04/08/2004 | US20040067932 Synergistic mixture; anticancer agents; therapy for skin cancer |
| 04/08/2004 | US20040067927 Substituted alkyldiamines |
| 04/08/2004 | US20040067922 Pharmaceutical composition for treatment of phimosis using topical corticosteroid |
| 04/08/2004 | US20040067918 Combination of an aldosterone receptor antagonist and nicotinic acid or a nicotinic acid derivative |
| 04/08/2004 | US20040067916 Method for treating, inhibiting or preventing pathogenic change resulting from vascular injury with an aldosterone antagonist |
| 04/08/2004 | US20040067915 Synergistic mixture; bioavailability |
| 04/08/2004 | US20040067910 Pharmaceutical or cosmetic composition and use of a pkc inhibitor with an mmp inhibitor for inhibiting langerhans' cell migration |
| 04/08/2004 | US20040067905 Nucleic acid compositions for stimulating immune responses |
| 04/08/2004 | US20040067901 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase |
| 04/08/2004 | US20040067885 Use of inhibitors for the treatment of RTK-hyperfunction-induced disorders, particularly cancer |
| 04/08/2004 | US20040067883 Prevent gene expression; anticancer agents |
| 04/08/2004 | US20040067878 Novel lipopeptides as antibacterial agents |
| 04/08/2004 | US20040067586 Comprises viral nucleotide sequences coding protein for treatment of tumors; gene therapy |
| 04/08/2004 | US20040067538 Prevention and treatment of amyloid-associated disorders |
| 04/08/2004 | US20040067515 Human proteinase molecules |
| 04/08/2004 | US20040067504 Novel zacrp8 polypeptides, polynucleotides encoding the polypeptides, and related compositions and methods of using them; useful in the study of collagen dimerization or oligomerization or in formation of fusion proteins |
| 04/08/2004 | US20040067500 Compositions and methods relating to the peroxisomal proliferator activated receptor-alpha mediated pathway |
| 04/08/2004 | US20040067490 Nucleic acid sequences, and antibodies that immunospecifically bind to the polypeptide, their derivatives, variants, mutants, or fragments of the novel polypeptide, polynucleotide, or antibody specific to the polypeptide |
| 04/08/2004 | US20040067261 Method for treating a mammal by administration of a compound having the ability to release CO, compounds having the ability to release CO and pharmaceutical compositions thereof |
| 04/08/2004 | US20040067256 Novel modified release formulation |
| 04/08/2004 | US20040067253 Pharmaceutical preparation, method for its production as well as its use |
| 04/08/2004 | US20040067252 Novel modified release formulation |
| 04/08/2004 | US20040067241 Comtrol a/k/a Virex antiviral composition |
| 04/08/2004 | US20040067232 Methods for treating autoimmune diseases in a subject and in vitro diagnostic assays |
| 04/08/2004 | US20040067230 Administering factor XIII. |
| 04/08/2004 | US20040067224 Enternal formulation |
| 04/08/2004 | US20040067222 Regulation of glucocorticoid concentration |
| 04/08/2004 | CA2503510A1 Prebiotic and preservative uses of oil-emulsified probiotic encapsulations |
| 04/08/2004 | CA2500360A1 Methods and compositions for the treatment of autoimmune disorders using clofarabine |
| 04/08/2004 | CA2500210A1 Cholesterol efflux and uses thereof |
| 04/08/2004 | CA2499843A1 Novel compositions and methods for the treatment of psoriasis |
| 04/08/2004 | CA2499501A1 Prophylactic docosahexaenoic acid therapy for patients with subclinical inflammation |
| 04/08/2004 | CA2499170A1 Methods and compositions for treatment of neurological disorder |
| 04/08/2004 | CA2499038A1 Monoacylated betulin and dihydrobetulin derivatives, preparation thereof and use thereof |
| 04/08/2004 | CA2498483A1 Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome |
| 04/08/2004 | CA2498423A1 Combination drug |
| 04/08/2004 | CA2492468A1 .beta.-hydroxyphenylalkylamines and their use for treating glaucoma |
| 04/07/2004 | EP1405913A2 Process for improving the production of 5R clavams |